Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 10/20 | 0.60 |
| ▸ | ABCC8 | Q09428 | 10/20 | 0.60 |
| ▸ | KCNJ11 | Q14654 | 10/20 | 0.60 |
| ▸ | KCNJ8 | Q15842 | 10/20 | 0.60 |
| ▸ | GPR174 | Q9BXC1 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6928301 | 0.92 | ABCC9 (0.50) | ABCC9ABCC8KCNJ11KCNJ8GPR174 | |
| SCHEMBL7835693 | 0.92 | ABCC9 (0.52) | ABCC9ABCC8KCNJ11KCNJ8GPR174 | |
| SCHEMBL6436430 | 0.88 | MEN1 (0.48) | ABCC9ABCC8KCNJ11KCNJ8GPR174 | |
| SCHEMBL6904653 | 0.88 | MEN1 (0.48) | ABCC9ABCC8KCNJ11KCNJ8GPR174 | |
| SCHEMBL7947122 | 0.87 | ABCC9 (0.65) | ABCC9ABCC8KCNJ11KCNJ8 | |
| SCHEMBL5227900 | 0.85 | MEN1 (0.53) | ABCC9ABCC8KCNJ11KCNJ8MEN1 | |
| SCHEMBL8878451 | 0.85 | KDM4E (0.65) | ABCC9ABCC8KCNJ11KCNJ8GPR174 | |
| SCHEMBL7833415 | 0.85 | ALDH1A1 (0.54) | ABCC9ABCC8KCNJ11KCNJ8MEN1 | |
| SCHEMBL6910323 | 0.84 | MEN1 (0.49) | ABCC9ABCC8KCNJ11KCNJ8GPR174 | |
| SCHEMBL7097522 | 0.83 | ABCC9 (0.57) | ABCC9ABCC8KCNJ11KCNJ8GPR174 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0539154-B1 | Acridine-1,8-dione-derivatives as therapeutic agents | ZENECA LTD (GB) | 1997-12-29 | — | — | EP | claimed |
| US-5340819-A | Method for treating urinary incontinence using 9-(3-nitrophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H) acridinedione | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-08-23 | — | — | US | claimed |
| EP-0539154-A1 | Acridine-1,8-dione-derivatives as therapeutic agents | ZENECA LIMITED (GB) | 1993-04-28 | — | — | EP | claimed |
| US-6265127-B1 | 1, 4-dihydrophyridine charge control agents for electrostatographic toners and developers | EASTMAN KODAK COMPANY | 2001-07-24 | — | — | US | disclosed |
| EP-1109070-A2 | 1,4-Dihydropyridine charge control agents for electrostatographic toners and developers | EASTMAN KODAK COMPANY (US) | 2001-06-20 | — | — | EP | disclosed |
| EP-0665834-B1 | QUINOLONE AND ACRIDINONE DERIVATIVES FOR THE TREATMENT OF URINARY INCONTINENCE | ASTRAZENECA AB (SE) | 2001-05-30 | — | — | EP | disclosed |
| US-5622964-A | ADMINISTERING 4,6,7,8-TETRAHYDRO-5(1H)-QUINOLONE DERIVATIVE TO TREAT ASTHMA IN MAMMALS | ZENECA LIMITED (GB) | 1997-04-22 | — | — | US | disclosed |
| US-5455253-A | For urinary incontinence | ZENECA LIMITED (GB) | 1995-10-03 | — | — | US | disclosed |
| EP-0665834-A1 | QUINOLONE AND ACRIDINONE DERIVATIVES FOR THE TREATMENT OF URINARY INCONTINENCE | ZENECA LIMITED (GB) | 1995-08-09 | — | — | EP | disclosed |
| WO-1994008966-A1 | QUINOLONE AND ACRIDINONE DERIVATIVES FOR THE TREATMENT OF URINARY INCONTINENCE | ZENECA LIMITED (GB) | 1994-04-28 | — | — | WO | disclosed |
| US-4021434-A | CEREBRAL VASODILATORS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1977-05-03 | — | — | US | disclosed |